EXHIBIT 10.1
Apogee Therapeutics, Inc.
Exhibit 10.1
AGREEMENT REGARDING PARACHUTE PAYMENTS
THIS AGREEMENT REGARDING PARACHUTE PAYMENTS (this “Agreement”), dated as of [date], 2026 (the “Effective Date”), is made and entered into by and between Apogee Therapeutics, Inc., a Delaware corporation (the “Company”) and [name] (the “Individual” and together with the Company, the “Parties”).
WHEREAS, the Individual is employed by the Company and is a participant in the Apogee Therapeutics, Inc. Executive Severance Policy (the “Executive Severance Policy”);
WHEREAS, the Company is a party to that certain Agreement and Plan of Merger, dated June 18, 2026 (the “Merger Agreement”), by and among the Company, Andor LLC, a Delaware limited liability company, Andor Merger Co., a Delaware corporation and, solely for the limited purposes set forth therein, AbbVie Inc., a Delaware corporation (“AbbVie”) whereby the Company will be acquired by AbbVie (the “Transaction”); and
…